These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group Genet Med; 2007 Dec; 9(12):819-25. PubMed ID: 18091431 [TBL] [Abstract][Full Text] [Related]
4. CYP450 genotype and aggressive behavior on selective serotonin reuptake inhibitors. Ekhart C; Matic M; Kant A; van Puijenbroek E; Schaik RV Pharmacogenomics; 2017 May; 18(7):613-620. PubMed ID: 28470107 [TBL] [Abstract][Full Text] [Related]
5. Neither cytochrome P450 family genes nor neuroendocrine factors could independently predict the SSRIs treatment in the Chinese Han population. Zhang X; Yu T; Li X; Li X; Huang X; Li X; He L; He G; Sun X Pharmacopsychiatry; 2014 Mar; 47(2):60-6. PubMed ID: 24488700 [TBL] [Abstract][Full Text] [Related]
6. Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review. Regan KL J Cardiovasc Nurs; 2008; 23(6):489-96. PubMed ID: 18953212 [TBL] [Abstract][Full Text] [Related]
7. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864 [TBL] [Abstract][Full Text] [Related]
8. [Use of antidepressant drugs in schizophrenic patients with depression]. Micallef J; Fakra E; Blin O Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628 [TBL] [Abstract][Full Text] [Related]
9. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence. Zhu J; Klein-Fedyshin M; Stevenson JM Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193 [TBL] [Abstract][Full Text] [Related]
10. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation. Edwards SJ; Hamilton V; Nherera L; Trevor N Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258 [TBL] [Abstract][Full Text] [Related]
11. Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation. Koren G; Ornoy A Pharmacogenomics; 2018 Sep; 19(14):1139-1145. PubMed ID: 30105921 [TBL] [Abstract][Full Text] [Related]
12. Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils. Rasmussen-Torvik LJ; McAlpine DD Depress Anxiety; 2007; 24(5):350-7. PubMed ID: 17096399 [TBL] [Abstract][Full Text] [Related]
13. Serotonin transporter gene (5-HTTLPR) polymorphism and efficacy of selective serotonin reuptake inhibitors--do we have sufficient evidence for clinical practice. Karlović D; Karlović D Acta Clin Croat; 2013 Sep; 52(3):353-62. PubMed ID: 24558768 [TBL] [Abstract][Full Text] [Related]
14. Interpreting and applying CYP450 genomic test results to psychotropic medications. Caley CF J Pharm Pract; 2011 Oct; 24(5):439-46. PubMed ID: 21940601 [TBL] [Abstract][Full Text] [Related]
15. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients. Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680 [TBL] [Abstract][Full Text] [Related]
16. Effect of Cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors. Probst-Schendzielorz K; Viviani R; Stingl JC Expert Opin Drug Metab Toxicol; 2015; 11(8):1219-32. PubMed ID: 26028357 [TBL] [Abstract][Full Text] [Related]
17. Too soon to judge value of pharmacogenetic testing in selecting antidepressant. Thompson CA Am J Health Syst Pharm; 2007 Mar; 64(5):453. PubMed ID: 17322153 [No Abstract] [Full Text] [Related]
18. [Apathy syndrome in depressed patients previously treated with selective serotonin reuptake inhibitors]. Petrova NN; Markin AV Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):111-117. PubMed ID: 32105278 [TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis. Khanassov V; Hu J; Reeves D; van Marwijk H Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774 [TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter polymorphism and bleeding time during SSRI therapy. Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]